SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-257271
Filing Date
2023-10-17
Accepted
2023-10-17 07:10:04
Documents
15
Period of Report
2023-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d518980d8k.htm   iXBRL 8-K 34588
2 EX-10.1 d518980dex101.htm EX-10.1 836391
3 EX-10.2 d518980dex102.htm EX-10.2 205588
4 EX-10.3 d518980dex103.htm EX-10.3 144355
  Complete submission text file 0001193125-23-257271.txt   1591737

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA asmb-20231015.xsd EX-101.SCH 2863
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20231015_lab.xml EX-101.LAB 17995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20231015_pre.xml EX-101.PRE 11270
9 EXTRACTED XBRL INSTANCE DOCUMENT d518980d8k_htm.xml XML 3362
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 231328445
SIC: 2834 Pharmaceutical Preparations